Trialbee has launched their new patient-centric platform Trialbee Health, which will improve patient access to clinical research. The Trialbee Health platform will act as an important step in Trialbee’s continued work to improve patient access to groundbreaking treatments by enabling a closer connection between all stakeholders involved in drug development.

Trialbee Health is Trialbee’s new platform for patients, caregivers and family members interested in learning about and engaging in clinical research.

Trialbee Health provides approachable and patient-friendly information about the clinical trial process, what it means to participate in a clinical trial, and answers frequently asked questions about clinical research. As a part of Trialbee’s Patient Recruitment offering, the platform also provides research sponsors with the possibility to market their studies to the Trialbee Health community.

The Trialbee Health platform will continuously develop with new features and services that bring not only sponsors, patients and investigators together, but also break down the barriers between clinical research and healthcare.

– Our new patient-focused brand Trialbee Health gives us the opportunity to further expand our patient-targeted services and is a key step in our journey towards holistic digitalization of clinical research. We have noticed that there is a need for better connection between research stakeholders, and Trialbee Health will act as a platform for communication, information, and marketing of clinical trials to make the study journey more streamlined for everyone involved, says Max Westling, Business Developer at Trialbee.

With the launch of Trialbee Health, Trialbee is also revamping their market offerings on a brand new sponsor-targeted information platform (trialbee.com).

– We continue to work towards our core mission to accelerate health by engaging patients in clinical research. Trialbee Health and the re-launched trialbee.com mark two important steps on our journey and we are very excited about the future expansion of our services, says Max Westling.